XSTO
INVE B
Market cap126bUSD
Sep 17, Last price
406.15SEK
1D
0.94%
1Q
3.83%
Jan 2017
377.26%
Name
Investor AB
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Investor AB (publ), a venerable venture capital firm, concentrates its investment efforts across mature, middle-market entities, growth capital opportunities, and leveraged buyouts. The company organizes its diverse operations into four distinct business segments: Core Investments, Private Equity, Operating Investments, and Financial Investments. Within its Core Investments division, Investor AB targets listed companies within the healthcare, financial services, information technology, and fintech industries. It typically seeks significant minority stakes in these enterprises, aiming for global reach and an active presence on the company's board of directors. The Operating Investments arm focuses predominantly on medium-to-large enterprises based in Northern Europe. Here, the firm either secures a controlling stake or a substantial minority position that grants considerable influence over its portfolio companies, investing in both publicly traded and privately held entities. The Private Equity segment encompasses both venture capital and buyout strategies. Its venture capital activities are managed via Investor Growth Capital, a dedicated subsidiary. This arm targets companies across the information technology, technology, engineering, financial services, and healthcare sectors in Europe, the United States, and Asia. It engages with companies from their startup phase through to expansion-ready stages, committing between SEK 20 million (approximately $2.94 million) and SEK 200 million (approximately $29.43 million) per investment. These venture capital endeavors typically involve acquiring minority equity stakes, with an anticipated ownership duration of three to seven years. For buyouts, Investor AB invests through its affiliated fund manager, EQT, which specializes in leveraged buyout opportunities within medium-sized, mature businesses located in Northern Europe and Greater China. Across all its private equity holdings, the firm typically aims for exits within a three to seven-year timeframe and frequently seeks board representation in its portfolio companies. Its Financial Investments involve acquiring minority interests in various financial instruments, generally with a shorter investment horizon. Established in 1916, Investor AB (publ) is headquartered in Stockholm, Sweden, and maintains a global footprint with additional offices in Amsterdam, Netherlands; Beijing and Hong Kong, China; Menlo Park, California; New York, New York; and Tokyo, Japan.
Related entities
Subsidiaries (22)
Aktiebolaget Investor Group Finance
Aleris Healthcare AB
Innax AB
Invaw Invest AB
Affibody Medical AB
Atlas Antibodies AB
Duba AB
Instoria Sweden AB
Investor Growth Capital Aktiebolag
Investor Investments Holding Aktiebolag
Invifed 3 AB
M&J AIRLAID PRODUCTS A/S
MOLNLYCKE HEALTH CARE
Molnlycke Health Care AB
Molnlycke Holding AB
Passim AB
Permobil Holding AB
Piab Management AB
TAWI Aktiebolag
Vectura 2 AB
Key people
President, Chief Executive Officer, Member of the Management Group, Member of the Extended Management Group, Director · since 2017
Independent Vice Chairman of the Board · since 2015
Co-Head of Patricia Industries, Member of the Extended Management Group · since 2017
Director · since 2018
Independent Director · since 2012
Independent Director · since 2014
Independent Director · since 2010
Independent Director · since 2014
Independent Chairman of the Board · since 2005
Headquarters & legal address
C/O Investor Aktiebolag
Stockholm, AB 103 32
SE
Stockholm, AB 103 32
SE
Valuation
Title SEK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||